Pfizer has asked the FDA to approve its Covid pill Paxlovid, a move toward selling the drug commercially, rather than only to the federal government as currently allowed
Treatment that has been available under emergency-use authorization could be marketed and sold commercially if approved
If you have had Covid before, why can you get it again? WSJ’s Daniela Hernandez explains what the possibility of reinfections means for the future of public-health policy and the Covid-19 pandemic. Illustration: David Fang
Ireland Latest News, Ireland Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer signs new $3.2 billion COVID vaccine deal with U.S. governmentPfizer Inc and partner BioNTech SE said on Wednesday they signed a $3.2 billion deal with the U.S. government for 105 million doses of their COVID-19 vaccine, which could be delivered as soon as later this summer.
Read more »
BioNTech, Pfizer to start testing next-generation vaccine for coronavirusesThe two partners, makers of the Western world's most widely used Covid-19 shot, are currently discussing with regulators enhanced versions of their established shot to better protect against the Omicron variant and its sublineages.
Read more »
Pfizer Says Updated Vaccines Boost Protection Against OmicronPfizer and BioNTech announced that their two Omicron-targeted vaccines are safe and effective against the coronavirus, including the latest Omicron subvariants. This new formulation could be used as a fourth shot — or a second booster — to better protect against another coronavirus surge expected this fall and winter.
Read more »
Paxlovid Cuts Omicron Hospitalizations by 45% - MedicineNet Health NewsPaxlovid appears to living up to its reputation as the Tamiflu treatment for COVID-19, maintaining its effectiveness even against emerging variants, a new study shows.
Read more »